SCHEMBL3356934

SCHEMBL3356934

COC1CCC(C(=O)Oc2ccc(/C=C/C(=O)O)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.54
ATM Q13315 1/20 0.54
SMN1; SMN2 Q16637 4/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ELANE P08246 2/20 0.46
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 5/20 0.45
GAA P10253 1/20 0.45
F3 P13726 1/20 0.41
SRD5A2 P31213 1/20 0.41
CA12 O43570 1/20 0.41
AKR1B10 O60218 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
ESR1 P03372 1/20 0.41
CA3 P07451 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3356939 1.00 THRB (0.54) THRBATMSMN1; SMN2HTTKMT2A
SCHEMBL22166808 0.89 THRB (0.56) THRBATMSMN1; SMN2HTTKMT2A
SCHEMBL3358696 0.87 THRB (0.48) THRBATMSMN1; SMN2HTTKMT2A
SCHEMBL3358698 0.87 THRB (0.48) THRBATMSMN1; SMN2HTTKMT2A
SCHEMBL3357029 0.86 THRB (0.53) THRBATMSMN1; SMN2HTTKMT2A
SCHEMBL3357022 0.86 THRB (0.53) THRBATMSMN1; SMN2HTTKMT2A
SCHEMBL18874033 0.86 HDAC1 (0.50) THRBATMSMN1; SMN2HTTKMT2A
SCHEMBL18874038 0.84 HPGD (0.44) SMN1; SMN2HTTKMT2ATDP1ELANE
SCHEMBL3360421 0.84 THRB (0.45) THRBATMSMN1; SMN2HTTKMT2A
SCHEMBL3360416 0.84 THRB (0.45) THRBATMSMN1; SMN2HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210340330-A1 PHOTOALIGNING MATERIALS Rolic Technologies AG (CH) 2021-11-04 US disclosed
US-20200223984-A1 PHOTOALIGNING MATERIALS Rolic Technologies AG (CH) 2020-07-16 US disclosed
US-10696795-B2 Photoaligning materials Rolic Technologies AG (CH) 2020-06-30 US disclosed
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group ROLIC AG (CH) 2019-02-19 US disclosed
EP-2152660-B1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2016-05-11 EP disclosed
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2010-02-25 US disclosed
EP-2152660-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP Rolic AG (CH) 2010-02-17 EP disclosed
WO-2008145225-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2008-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group DDC, ALAD, DYNC1LI1 THRB 4854/4885ATM 2265/4885SMN1; SMN2 2470/4885
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP DDC, ALAD, DYNC1LI1 THRB 4854/4885ATM 2265/4885SMN1; SMN2 2470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.